KRAS and pachyonychia congenita: In a study by Melo et al. the authors identify glypican-1 (GPC1) + circulating exosomes (crExos) containing mutant KRAS mRNA as reliable biomarkers for early PC detection, while also suggesting that GPC1+ crExos are a superior prognostic marker compared to CA19-9 [44,45].